Search

Your search keyword '"Cascone, I"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Cascone, I" Remove constraint Author: "Cascone, I" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
47 results on '"Cascone, I"'

Search Results

5. TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.

6. Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines.

7. Satisfaction and results of the subareolar incision as treatment for gynecomastia in adolescents: experience of two centers.

9. Three-dimensional characterization of developing and adult ocular vasculature in mice using in toto clearing.

10. Chromosome Instability in Pony of Esperia Breed Naturally Infected by Intestinal Strongylidae.

11. Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma.

12. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

13. Polymerization-Induced Self-Assembly (PISA) for in situ drug encapsulation or drug conjugation in cancer application.

14. Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation.

15. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.

16. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

17. Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option.

18. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.

19. Fabrication of large pore mesoporous silica microspheres by salt-assisted spray-drying method for enhanced antibacterial activity and pancreatic cancer treatment.

20. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.

21. The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells.

22. Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

23. A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.

24. Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.

26. Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.

27. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.

28. Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.

29. The Pro-apoptotic STK38 Kinase Is a New Beclin1 Partner Positively Regulating Autophagy.

30. Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathway.

31. Neuroligin 1 induces blood vessel maturation by cooperating with the α6 integrin.

32. Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.

33. Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study.

35. On the expansion of "dangerous" gene repertoires by whole-genome duplications in early vertebrates.

36. RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

37. Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry.

38. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.

39. Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors.

40. A new computational approach to analyze human protein complexes and predict novel protein interactions.

41. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1.

42. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.

43. Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA.

44. Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1.

45. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival.

46. Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies.

47. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.

Catalog

Books, media, physical & digital resources